| Literature DB >> 21494253 |
Ayelet Dar1, Amir Schajnovitz1, Kfir Lapid1, Alexander Kalinkovich1, Tomer Itkin1, Aya Ludin1, Wei-Ming Kao2, Michela Battista2, Melania Tesio1, Orit Kollet1, Neta Netzer Cohen1, Raanan Margalit1, Eike C Buss1, Francoise Baleux3, Shinya Oishi4, Nobutaka Fujii4, Andre Larochelle5, Cynthia E Dunbar5, Hal E Broxmeyer6, Paul S Frenette2, Tsvee Lapidot1.
Abstract
Steady-state egress of hematopoietic progenitor cells can be rapidly amplified by mobilizing agents such as AMD3100, the mechanism, however, is poorly understood. We report that AMD3100 increased the homeostatic release of the chemokine stromal cell derived factor-1 (SDF-1) to the circulation in mice and non-human primates. Neutralizing antibodies against CXCR4 or SDF-1 inhibited both steady state and AMD3100-induced SDF-1 release and reduced egress of murine progenitor cells over mature leukocytes. Intra-bone injection of biotinylated SDF-1 also enhanced release of this chemokine and murine progenitor cell mobilization. AMD3100 directly induced SDF-1 release from CXCR4(+) human bone marrow osteoblasts and endothelial cells and activated uPA in a CXCR4/JNK-dependent manner. Additionally, ROS inhibition reduced AMD3100-induced SDF-1 release, activation of circulating uPA and mobilization of progenitor cells. Norepinephrine treatment, mimicking acute stress, rapidly increased SDF-1 release and progenitor cell mobilization, whereas β2-adrenergic antagonist inhibited both steady state and AMD3100-induced SDF-1 release and progenitor cell mobilization in mice. In conclusion, this study reveals that SDF-1 release from bone marrow stromal cells to the circulation emerges as a pivotal mechanism essential for steady-state egress and rapid mobilization of hematopoietic progenitor cells, but not mature leukocytes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21494253 PMCID: PMC4175714 DOI: 10.1038/leu.2011.62
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528